Smoking
Conditions
Keywords
Tobacco, cigarettes, cessation, intervention, young adults, Internet, social media, mobile health
Brief summary
This randomized clinical trial will test the efficacy of a Facebook intervention based on the Transtheoretical Model (Prochaska and DiClemente) and US Public Health Service Clinical Practice Guidelines with young adults who smoke cigarettes who are age 18 to 25 (N=480).
Detailed description
Participants will be randomized to one of two conditions: (1) a Facebook-delivered intervention tailored to readiness to quit smoking; or (2) the control condition (referral to the Smokefree.gov website). The intervention will include 12 weeks of Facebook-based messages and activities tailored to participants' stage of change. Assessments will occur at baseline, 3, 6, and 12 months follow-up. Assessments will include measures on smoking patterns and thoughts about abstinence. All participants who report no past 7-day smoking will be asked to give biochemical verification of smoking status with saliva cotinine test kits that will be mailed to participants.
Interventions
BEHAVIORALFacebook intervention
90 days of Facebook messaging, weekly Ask the Doctor sessions
BEHAVIORALSmokefree.gov
referral to the NCI Smokefree.gov website
Sponsors
National Institute on Drug Abuse (NIDA)
University of California, San Francisco
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
Yes
Inclusion criteria
* ages 18-25 years old * english literate * have access to Smartphone or computer with camera * indicate they go on Facebook most (≥ 4) days per week * have smoked ≥100 cigarettes in their lives and currently smoke at least 1 cigarette per day on 3 or more days of the week
Exclusion criteria
* do not read English * younger than 18 or older than 25 years of age * do not have access to a Smartphone or computer with a camera * only go on Facebook 3 or fewer days a week * have smoked less than 100 cigarettes in their lifetime or do not currently smoke at least 1 cigarette per day on 3 or more days of the week
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 7-day point prevalence abstinence at 3 months | 3 months post baseline | Reports of no smoking in the 7 days prior to the 3 month assessment. Biochemical verification of abstinence will also be recorded. |
| 7-day point prevalence abstinence at 6 months | 6 months post baseline | Reports of no smoking in the 7 days prior to the 6 month assessment. Biochemical verification of abstinence will also be recorded. |
| 7-day point prevalence abstinence at 12 months | 12 months post baseline | Reports of no smoking in the 7 days prior to the 12 month assessment. Biochemical verification of abstinence will also be recorded. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Reduction in cigarettes smoked by at least 50% between Baseline and each follow-up timepoint | 3, 6, and 12 months post baseline | Reduction will be assessed at 3, 6, and 12 month follow-ups. |
| Quit attempts | 3, 6, and 12 month post-baseline | Quit attempt during the follow-up period at 3, 6, and 12 months post-baseline. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Health risk behaviors | 3, 6, and 12 months post baseline | We will assess prevalence rates of health risk behaviors other than smoking including recent alcohol and illicit drug use, poor sleep quality, sedentary behavior, poor diet, depression, and high risk sexual behavior. |
Countries
United States
Outcome results
None listed